Global Intravenous Solutions Market Growth 2023-2029

Global Intravenous Solutions Market Growth 2023-2029

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

LPI (LP Information)' newest research report, the “Intravenous Solutions Industry Forecast” looks at past sales and reviews total world Intravenous Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous Solutions sales for 2023 through 2029. With Intravenous Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Solutions industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intravenous Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Solutions and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Solutions.

The global Intravenous Solutions market size is projected to grow from US$ 10760 million in 2022 to US$ 16760 million in 2029; it is expected to grow at a CAGR of 16760 from 2023 to 2029.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Crystalloids

Colloids

Others

Segmentation by application

Basic IV Solutions

Nutrient Infusion Solution

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Baxter

Kelun Group

Fresenius Kabi

Otsuka

ICU Medical

Fresenius Kabi

JW Life Science

B. Braun Melsungen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Solutions market?

What factors are driving Intravenous Solutions market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Solutions market opportunities vary by end market size?

How does Intravenous Solutions break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.